(Q37842638)

24 August 2017

1 reference

title

What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? (English)

1 reference

24 August 2017

1 reference

1 reference

Iain B McInnes

2

0 references

Eddy Liew

series ordinal

3

object named as

Foo Y Liew

1 reference

24 August 2017

Shauna Culshaw

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Journal of Clinical Periodontology

24 August 2017

published in

1 reference

24 August 2017

volume

38 Suppl 11

1 reference

24 August 2017

page(s)

106-113

1 reference

IL-1, IL-18, and IL-33 families of cytokines

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Rheumatoid arthritis and smoking: putting the pieces together

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Evidence that cytokines play a role in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Bisphosphonate therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Parvovirus B19: its role in chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Epstein-Barr virus and rheumatoid arthritis: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

The role of toll-like receptors in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Evolving concepts of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Mast cells express IL-17A in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Abandoned therapies and unpublished trials in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Genes and environment in arthritis: can RA be prevented?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Immunity to citrullinated proteins in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Cytokines in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Role for TNF in atherosclerosis? Lessons from autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Cytokines as therapeutic targets: advances and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Mechanisms of Disease: the link between RANKL and arthritic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

New therapies for treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

IL-17 as a future therapeutic target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Understanding the genetic contribution to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Control of inflammation and periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Cytokine responses against periodontal infection: protective and destructive roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01669.X

10.1111/J.1600-051X.2010.01669.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference